Contract development is a business built on judgement. The formulation decisions taken in the first weeks of a project determine which markets stay open to it years later. Those decisions are made by people, so it is reasonable that you should know who they are.
Leads the direction of the business across Raised Pharma’s Canadian, US and Indian operations, with overall responsibility for how the company serves clients from formulation through to regulatory registration.
Leads research and development across oral solid, oral liquid and topical semisolid dosage forms, including pre-formulation, formulation development, bioequivalence strategy and the analytical work supporting registration dossiers.
Manages regulatory submissions and dossier preparation across our markets, including CTD and eCTD compilation, labelling review and correspondence with regulatory authorities in Canada, the USA, the EU and the Gulf.
Product development decisions carry clinical consequences. Our advisory board brings qualified medical input to formulation, claims and safety — the areas where commercial ambition most often meets regulatory reality.
Provides medical and regulatory guidance on product development, advising on clinical appropriateness, safety considerations and the evidence needed to support claims across the markets we serve.
Advises on clinical evidence and research strategy, including the design and interpretation of the data used to substantiate product claims and support regulatory submissions.
Advises on clinical research and evidence review, supporting the assessment of safety and efficacy data that underpins product development and market registration.
When a company brings us a product, they are rarely bringing us just a formula. They are bringing an ambition — to reach patients in a market they do not yet understand, under rules that change from country to country, on a timeline their investors are already counting.
Raised Pharma exists to carry that weight with them.
We are a Canadian contract development company, and we chose deliberately to work across the whole path rather than one segment of it. Formulation, stability, sourcing, quality and regulatory registration sit under one roof, because the alternative — a client coordinating four vendors who do not speak to one another — is where good products lose years.
From our head office in Mississauga, and with operations in the United States and India, we support clients entering Canada, the United States, the European Union and the Gulf. Each of those markets asks different questions of the same product. Knowing those differences early, before a formula is locked, is usually the difference between a launch and a rejection.
I want to be clear about how we work. We do not promise approval timelines we cannot control, and we do not tell clients what they hope to hear about a regulatory pathway. Where a requirement is uncertain, we say so, and we go and confirm it. In this industry, an inconvenient answer given early is worth more than a comfortable one given late.
What we do commit to is rigour, honesty about risk, and the quality standards these markets demand.
If you are bringing a product to market, we would welcome the conversation.
Behind the names above sits a team of formulation scientists, analytical chemists, quality assurance specialists and regulatory professionals across our Canadian, US and Indian operations — the people who do the daily work of taking a product from concept to registration.
Working with us starts with a conversation. Tell us the product, the dosage form and the markets you are aiming at, and we will tell you plainly whether we are the right partner for it.
Email: info@raisedpharma.com Phone: +1 (716)-777-4800